244th ENMC international workshop: Newborn screening in spinal muscular atrophy May 10–12, 2019, Hoofdorp, The Netherlands

244th ENMC international workshop: Newborn screening in spinal muscular atrophy May 10–12, 2019, Hoofdorp, The Netherlands

Veure altres versions (1)

Dades bibliogràfiques
Autors principals:	Dangouloff, T, Burghes, A, Tizzano, EF, Servais, L
Altres autors:	NBS SMA Study Group
Format:	Journal article
Idioma:	English
Publicat:	Elsevier 2019

Ítems similars

244th ENMC international workshop: Newborn screening in spinal muscular atrophy May 10–12, 2019, Hoofdorp, The Netherlands
per: Dangouloff, T, et al.
Publicat: (2019)

Infantile spinal muscular atrophy: Therapeutic (R)evolution
per: Daron, A, et al.
Publicat: (2019)

Clinical evidence supporting early treatment of patients with spinal muscular atrophy: Current perspectives
per: Dangouloff, T, et al.
Publicat: (2019)

Spinal muscular atrophy.
per: Talbot, K, et al.
Publicat: (2001)

SMA-EUROPE workshop report: Opportunities and challenges in developing clinical trials for spinal muscular atrophy in Europe.
per: Kayadjanian, N, et al.
Publicat: (2013)

New treatments in spinal muscular atrophy: an overview of currently available data
per: Ramdas, S, et al.
Publicat: (2020)

Nusinersen treatment of spinal muscular atrophy: current knowledge and existing gaps
per: Gidaro, T, et al.
Publicat: (2018)

PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan
per: Noguchi, Yoriko, et al.
Publicat: (2022)

PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan
per: Noguchi, Yoriko, et al.
Publicat: (2022)

(S)un (M)ay (A)rise on SMA: the hope of a region without spinal muscular atrophy
per: Boemer, F, et al.
Publicat: (2019)

Modeling spinal muscular atrophy in Drosophila.
per: Chang, H, et al.
Publicat: (2008)

Chapter 16 Spinal Muscular Atrophy
per: Talbot, K, et al.
Publicat: (2003)

Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
per: Finkel, RS, et al.
Publicat: (2017)

Splice-switching therapy for spinal muscular atrophy.
per: Meijboom, K, et al.
Publicat: (2017)

Sitting in patients with spinal muscular atrophy type 1 treated with nusinersen
per: Aragon-Gawinska, K, et al.
Publicat: (2019)

Analysis of the survival of motor neuron (SMN1) gene mutations in Spinal Muscular Atrophy through models
per: Owen, N, et al.
Publicat: (2002)

MOLECULAR ANALYSIS OF CHILDHOOD-ONSET SPINAL MUSCULAR-ATROPHY
per: Theodosiou, A, et al.
Publicat: (1995)

Spinal muscular atrophy at the crossroads of basic science and therapy
per: Sleigh, J, et al.
Publicat: (2013)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
per: Bowerman, M, et al.
Publicat: (2017)

Spinal muscular atrophy at the crossroads of basic science and therapy.
per: Sleigh, J, et al.
Publicat: (2013)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
per: Bowerman, M, et al.
Publicat: (2017)

Spinal muscular atrophy: disease mechanisms and therapeutic approaches
per: Meijboom, K
Publicat: (2018)

186th ENMC international workshop: congenital myasthenic syndromes 24-26 June 2011, Naarden, The Netherlands.
per: Chaouch, A, et al.
Publicat: (2012)

186th ENMC International Workshop: Congenital myasthenic syndromes 24-26 June 2011, Naarden, The Netherlands
per: Chaouch, A, et al.
Publicat: (2012)

RESTORE: a prospective multinational registry of patients with genetically confirmed spinal muscular atrophy - rationale and study design
per: Finkel, RS, et al.
Publicat: (2020)

Reversible molecular pathology of skeletal muscle in spinal muscular atrophy.
per: Mutsaers, C, et al.
Publicat: (2011)

The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy.
per: Sleigh, J, et al.
Publicat: (2011)

Modelling of spinal muscular atrophy in D-melanogaster and C-elegans
per: Davies, K
Publicat: (2004)

Chapter 7 Spinal muscular atrophies and hereditary motor neuropathies.
per: Talbot, K, et al.
Publicat: (2007)

The changing natural history of spinal muscular atrophy type 1.
per: Oskoui, M, et al.
Publicat: (2007)

243rd ENMC international workshop: Developing guidelines for management of reproductive options for families with maternally inherited mtDNA disease, Amsterdam, the Netherlands, 22–24 March 2019
per: Poulton, J, et al.
Publicat: (2019)

Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy
per: Lombardi, V, et al.
Publicat: (2019)

Nusinersen versus sham control in later-onset spinal muscular atrophy
per: Mercuri, E, et al.
Publicat: (2018)

Invertebrate models of spinal muscular atrophy: Insights into mechanisms and potential therapeutics
per: Grice, S, et al.
Publicat: (2011)

From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?
per: Pennuto, M, et al.
Publicat: (2017)

Invertebrate models of spinal muscular atrophy: insights into mechanisms and potential therapeutics.
per: Grice, S, et al.
Publicat: (2011)

Drugs, genes and screens: the ethics of preventing and treating spinal muscular atrophy
per: Gyngell, C, et al.
Publicat: (2019)

Expression profiling in spinal muscular atrophy reveals an RNA binding protein deficit.
per: Anderson, K, et al.
Publicat: (2004)

Molecular and phenotypic reassessment of an infrequently used mouse model for spinal muscular atrophy
per: Gogliotti, R, et al.
Publicat: (2010)

Spinal muscular atrophies reveal motor neuron vulnerability to defects in ribonucleoprotein handling.
per: Anderson, K, et al.
Publicat: (2003)